1. S105: IN VIVO PDX CRISPR/CAS9 SCREENS REVEAL MUTUAL THERAPEUTIC TARGETS TO OVERCOME HETEROGENEOUS ACQUIRED CHEMO-RESISTANCE. (23rd June 2022) Authors: Wirth, A.-K.; Wange, L.; Vosberg, S.; Jayavelu, A. K.; Enard, W; Herold, T; Jeremias, I Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S253: THE SHEDDASE DOMAIN OF ADAM10 AUGMENTS THE INTERACTION OF LEUKEMIA CELLS WITH THE BONE MARROW NICHE IN VIVO AS SHOWN BY RECONSTITUTING PDX LEUKEMIA CELLS WITH CRISPR-CAS9-INDUCED KNOCKOUT. (23rd June 2022) Authors: Schmid, J. P.; Bahrami, E.; Becker, M.; Jayavelu, A. K.; Wirth, A.-K.; Jurinovic, V.; Öllinger, R.; Rad, R; Vick, B.; Mann, M.; Herold, T.; Jeremias, I. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗